A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide

Pennsylvania State University, Hershey

Ireland Cancer Center, Case Western Reserve University, Division of Hematology/Oncology, Cleveland

University of Texas Southwestern Medical Center, Dallas

Juranvinski Cancer Center - Medical Oncology, Hamilton

Princess Margaret Hospital, Toronto

Mc Gill University - Department of Oncology - Clinical Research Program, Montreal